Maine BioTek Inc
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Maine Biotek is focused to issues in fish pathology and in their quest for relevant vaccines to address diseases, principals of the firm are working their way through dozens of potential approaches. Once vaccines seems to have potential in the lab, Anderson and Clouthier continue their work at a Canadian government research facility in St. Andrews, New Brunswick. The first few BioTek vaccines to receive approval probably will be produced at an out-of-state facility, but, the hope is to build the sort of sanitary facility needed for vaccine production - both for ISA and a number of other fish diseases that the company is investigating -in Maine

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
A Multivalent Bacterial Vaccine for Atlantic Cod
Atlantic Cod Nodavirus Vaccine
Recombinant ISA Virus Vaccine
Preparation of an IHN Virus Whole Killed Vaccine: Retention of Neutralizing Epitope Integrity of the IHN Virus Glycoprotein During Viral
Recombinant Infectious Hematopoietic Necrosis (IHN ) Virus G Protein Vaccine